Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor use in healthy swine as an aid in the control of ileitis caused by Lawsonia intracellularis, an aid in the reduction of colonization by Lawsonia, and an aid…
LEARN MOREFor treatment of respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella Choleraesuis, Streptococcus…
LEARN MOREFor treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and bovine interdigital phlegmon associated with…
LEARN MOREFor the vaccination of healthy 18-day old chicken embryos or chickens 1-day of age against standard and variant infectious bursal disease.
LEARN MORE